Medical device company Asensus Surgical (NYSE: ASXC) popped in trading on Thursday after announcing a collaboration with chip giant Nvidia (NVDA) to advance the development of Asensus’s Intelligent Surgical Unit (ISU).
The ISU will use Nvidia’s cutting-edge technology to enhance the ISU’s machine vision, image analytics, and augmented intelligence. The ISU provides surgeons with real-time digital tags, 3D measurements, and precise camera control. This collaboration aims to propel the ISU’s augmented intelligence capabilities and foster innovative clinical applications. As a part of this partnership, both companies will have early access to product roadmaps, which will result in synergistic development and novel business models for digital surgical solutions.
Today’s price surge aside, ASXC stock has declined by more than 18% year-to-date.
